Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet… Eikon Therapeutics (NAS: EIKN) is based in Millbrae, CA and was founded in 2019. It is now publicly traded; this page covers its private-market history, where its last recorded valuation was $972 million (Feb 2026). It has raised $1.5 billion.
Last price · $/share
—
Implied valuation
$971.7M
Total raised
$1.5B
Last round
—
No prints on record
No secondary trades in Eikon Therapeutics (NAS: EIKN) shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Where Eikon Therapeutics (NAS: EIKN) prices come from
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Eikon Therapeutics (NAS: EIKN) stock.
